These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 15207650)
1. The antidepressant mechanism of Hypericum perforatum. Mennini T; Gobbi M Life Sci; 2004 Jul; 75(9):1021-7. PubMed ID: 15207650 [TBL] [Abstract][Full Text] [Related]
2. Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients. Wurglics M; Schubert-Zsilavecz M Clin Pharmacokinet; 2006; 45(5):449-68. PubMed ID: 16640452 [TBL] [Abstract][Full Text] [Related]
3. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect]. Vacek J; Klejdus B; Kubán V Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301 [TBL] [Abstract][Full Text] [Related]
4. In vitro binding studies with two hypericum perforatum extracts--hyperforin, hypericin and biapigenin--on 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y1/Y2 receptors and dopamine transporters. Gobbi M; Moia M; Pirona L; Morizzoni P; Mennini T Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S45-8. PubMed ID: 11518075 [TBL] [Abstract][Full Text] [Related]
5. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models. Butterweck V; Christoffel V; Nahrstedt A; Petereit F; Spengler B; Winterhoff H Life Sci; 2003 Jun; 73(5):627-39. PubMed ID: 12770617 [TBL] [Abstract][Full Text] [Related]
6. Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extracts. Cervo L; Rozio M; Ekalle-Soppo CB; Guiso G; Morazzoni P; Caccia S Psychopharmacology (Berl); 2002 Dec; 164(4):423-8. PubMed ID: 12457273 [TBL] [Abstract][Full Text] [Related]
7. Potential antidepressant properties of IDN 5491 (hyperforin-trimethoxybenzoate), a semisynthetic ester of hyperforin. Cervo L; Mennini T; Rozio M; Ekalle-Soppo CB; Canetta A; Burbassi S; Guiso G; Pirona L; Riva A; Morazzoni P; Caccia S; Gobbi M Eur Neuropsychopharmacol; 2005 Mar; 15(2):211-8. PubMed ID: 15695067 [TBL] [Abstract][Full Text] [Related]
8. Hypericum perforatum subspecies angustifolium shows a protective activity on the consequences of unavoidable stress exposure at lower doses than Hypericum perforatum perforatum. Usai M; Leggio B; Grappi S; Nanni G; Gambarana C; Tolu P; Giachetti D; De Montis MG Pharmacopsychiatry; 2003 Nov; 36(6):283-7. PubMed ID: 14663651 [TBL] [Abstract][Full Text] [Related]
9. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers. Schulz HU; Schürer M; Bässler D; Weiser D Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501 [TBL] [Abstract][Full Text] [Related]
10. Acute and chronic actions of a dry methanolic extract of Hypericum perforatum and a hyperforin-rich extract on dopaminergic and serotonergic neurones in rat nucleus accumbens. Rommelspacher H; Siemanowitz B; Mannel M Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S119-26. PubMed ID: 11518060 [TBL] [Abstract][Full Text] [Related]
11. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature]. Bouron A; Lorrain E Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060 [TBL] [Abstract][Full Text] [Related]
12. Role of hyperforin in the pharmacological activities of St. John's Wort. Zanoli P CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771 [TBL] [Abstract][Full Text] [Related]
13. Hypericum perforatum, a source of neuroactive lead structures. Verotta L Curr Top Med Chem; 2003; 3(2):187-201. PubMed ID: 12570773 [TBL] [Abstract][Full Text] [Related]
14. St. John's wort: role of active compounds for its mechanism of action and efficacy. Butterweck V; Schmidt M Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet. Schulz HU; Schürer M; Bässler D; Weiser D Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160 [TBL] [Abstract][Full Text] [Related]
16. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers. Biber A; Fischer H; Römer A; Chatterjee SS Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():36-43. PubMed ID: 9684946 [TBL] [Abstract][Full Text] [Related]
17. Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology. Agrosi M; Mischiatti S; Harrasser PC; Savio D Phytomedicine; 2000 Dec; 7(6):455-62. PubMed ID: 11194173 [TBL] [Abstract][Full Text] [Related]
18. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L. Sosa S; Pace R; Bornancin A; Morazzoni P; Riva A; Tubaro A; Della Loggia R J Pharm Pharmacol; 2007 May; 59(5):703-9. PubMed ID: 17524236 [TBL] [Abstract][Full Text] [Related]
19. A study of the antidepressant activity of Hypericum perforatum on animal models. Gambarana C; Tolu PL; Masi F; Rinaldi M; Giachetti D; Morazzoni P; De Montis MG Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S42-4. PubMed ID: 11518074 [TBL] [Abstract][Full Text] [Related]
20. Researching the antidepressant actions of Hypericum perforatum (St. John's wort) in animals and man. Franklin M; Cowen PJ Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S29-37. PubMed ID: 11518072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]